Advanced Proteome Therapeutics Corp.: Advanced Proteome Therapeutics Announces Dr. Benjamin Krantz to Join Company as CEO
Advanced Proteome Therapeutics Corporation
(TSXV: APC) (FSE: 0E8)
( APC or the Company ), is pleased to announce that Dr. Benjamin Krantz will be joining the Company s US subsidiary Advanced Proteome Therapeutics Inc. ( APTI ) as CEO following the completion of his oncology fellowship at NYU Langone Health on July 1
st, 2021. Bill Dickie will continue his role as interim CEO of APTI until then and remain a member of the board of directors after.
Benjamin Krantz MD, MBA is the Chief Fellow in hematology/oncology at New York University Langone Medical Center and is currently on the Board of Directors at APTI. He completed his residency in internal medicine at New York-Presbyterian Hospital - Columbia University Medical Center during which time he analyzed investigator intellectual property disclosures as a Columbia Technology Ventures fellow. He subseque